A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis
Crossref DOI link:
Published Online: 2017-09-18
Published Print: 2017-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Ilag, Leodevico L.
Funding for this research was provided by:
Biovite Australia Pty Limited